AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2021
May 3, 2021
35221_dirs_2021-05-03_d5f9d07e-7278-47fe-9cff-50bd61cb8ef3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2021-04-29
Reporting Person: White Debra (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-29 | Employee Stock Option (Right to Buy) | $4.81 | A | 100000 | Acquired | 2031-04-29 | Common Stock (100000) | Direct |
Footnotes
F1: The option vests in 12 quarterly installments, commencing on June 30, 2021.
More from PAVmed Inc.
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Earnings Release
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Capital/Financing Update
2026
Feb 4
Regulatory Filings
2026
Jan 23